ARS Pharmaceuticals Growth Metrics (2021-2025) | SPRY

Growth Metrics Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) -18.24%-19.89%-23.12%358.02%-13.21%-11.99%-8.30%-17.14%-16.08%-14.22%-12.45%50.59%43.82%41.23%71.32%
Assets Growth (3y) -15.87%-15.43%-14.86%78.79%1.56%2.16%11.21%
Assets (QoQ) -3.98%-3.93%-82.57%408.53%-5.91%-7.80%3.83%-3.64%-4.59%-3.94%-6.18%-2.40%-2.47%-1.97%61.37%-6.79%-4.23%18.93%
Capital Expenditures Growth (1y) -84.56%-96.33%-65.52%116.43%819.05%36.36%43.33%-172.22%-56.99%26.67%225.58%431.87%9.64%15,081.58%-4,043.57%
Capital Expenditures Growth (3y) -15.18%-60.12%17.18%33.77%63.03%540.07%-470.86%
Capital Expenditures (QoQ) 340.44%-85.48%-981.61%102.74%4.76%36.36%320.00%53.17%-84.46%43.33%-311.63%191.21%-54.22%268.42%115.71%-69.87%6,239.56%-195.70%
Cash & Equivalents Growth (1y) -37.47%-39.20%-32.41%250.50%-62.45%-45.58%-70.21%-66.29%-36.26%-69.23%-34.49%-28.40%-28.82%40.72%50.18%
Cash & Equivalents Growth (3y) -46.91%-53.30%-49.10%-5.42%-44.56%-38.23%-33.58%
Cash & Equivalents (QoQ) -3.88%-16.41%-80.02%289.57%-6.54%-7.07%3.59%-58.26%35.46%-49.14%17.25%-21.09%-34.60%8.28%28.14%-21.55%29.29%15.55%
Cash from Investing Activities Growth (1y) 40.00%96.86%99.93%-100.31%-531,071.43%204,509.09%-155,376.67%20,765.87%92.37%-128.12%136.06%-490.80%441.41%484.08%-367.46%
Cash from Investing Activities Growth (3y) -524.22%-162.39%34.25%-65.07%1,014.95%1,202.51%-1,044.55%
Cash from Investing Activities (QoQ) -1,900.00%-5,622.57%201.70%-100.05%-4.76%-36.36%-320.00%-88,428.57%140.32%-203.72%155.83%-132.69%-48.55%232.99%-705.07%128.56%67.12%-192.61%
Cash from Operations Growth (1y) 43.24%50.66%70.28%-173.48%-79.48%-139.02%-124.62%15.09%46.01%56.33%-13.35%341.33%-507.18%-443.92%-225.20%
Cash from Operations Growth (3y) 18.07%19.85%8.87%14.62%-80.53%-78.39%-102.31%
Cash from Operations (QoQ) -15.85%-35.26%245.90%-124.83%-0.71%18.53%-260.74%39.36%-34.11%23.43%-36.37%61.45%-8.48%-98.75%390.34%-197.00%2.82%-18.83%
EBITDA Margin Growth (1y) -7.54M-17.48M17.37M0.22M0.07M
EBITDA Margin Growth (3y) 0.07M0.11M0.33M
EBITDA Margin (QoQ) -0.03M-0.21M-9.97M0.16M0.10M-0.05M0.01M0.01M
EBIT Growth (1y) -163.60%-224.76%-171.16%33.78%29.50%25.54%-20.97%561.54%-181.81%-210.39%-144.58%
EBIT Growth (3y) -73.66%-95.79%-100.19%
EBIT Margin Growth (1y) -9.25M-20.47M20.30M0.28M0.09M
EBIT Margin Growth (3y) 0.06M0.11M0.33M
EBIT Margin (QoQ) -0.03M-0.21M-11.25M0.20M0.11M-0.05M0.02M0.01M
EBIT (QoQ) 10.64%-4.51%-132.93%-21.17%-10.10%12.74%43.12%-29.00%-16.28%-41.77%317.02%-178.77%-28.07%-11.72%
EBT Growth (1y) -163.60%-224.76%-171.16%33.78%29.50%25.54%-20.97%561.54%-181.81%-210.39%-144.58%
EBT Growth (3y) -73.66%-95.79%-100.19%
EBT Margin Growth (1y) -9.25M-20.47M20.30M0.28M0.09M
EBT Margin Growth (3y) 0.06M0.11M0.33M
EBT Margin (QoQ) -0.03M-0.21M-11.25M0.20M0.11M-0.05M0.02M0.01M
EBT (QoQ) 10.64%-4.51%-132.93%-21.17%-10.10%12.74%43.12%-29.00%-16.28%-41.77%317.02%-178.77%-28.07%-11.72%
Enterprise Value Growth (1y) -111.36%-115.16%-261.87%-80.87%368.22%451.31%250.46%796.79%117.88%58.27%906.34%138.92%25.70%143.25%-41.30%
Enterprise Value Growth (3y) -12.76%-5.53%190.47%60.03%110.64%149.47%121.64%
Enterprise Value (QoQ) -37.44%-93.18%254.14%-175.19%16.50%27.20%141.85%954.37%9.36%-68.82%149.45%156.16%-20.56%98.24%-40.78%34.77%53.73%-52.16%
EPS (Basic) Growth (1y) 1.87%11.36%14.39%83.66%44.51%18.75%-25.00%828.57%-218.18%-253.85%-160.00%
EPS (Basic) Growth (3y) -20.11%-36.59%-40.65%
EPS (Basic) (QoQ) 10.64%-3.54%-129.15%53.72%19.28%0.00%56.25%-57.14%-18.18%-53.85%355.00%-168.63%-31.43%-13.04%
EPS (Weighted Average and Diluted) Growth (1y) 15.04%22.81%25.78%81.89%44.61%18.75%-25.00%828.57%-218.18%-253.85%-160.00%
EPS (Weighted Average and Diluted) Growth (3y) -14.40%-30.44%-34.11%
EPS (Weighted Average and Diluted) (QoQ) 11.33%-4.00%-79.29%48.62%19.43%0.00%56.25%-57.14%-18.18%-53.85%355.00%-168.63%-31.43%-13.04%
FCF Margin Growth (1y) -6.21M-16.55M16.55M0.12M0.06M
FCF Margin Growth (3y) 0.05M0.12M0.29M
FCF Margin (QoQ) -0.05M-0.15M-10.39M0.08M0.08M-0.06M0.02M0.02M
Free Cash Flow Growth (1y) 43.70%52.52%70.26%-171.95%-81.72%-138.69%-124.19%16.05%46.18%56.18%-14.06%340.86%-501.10%-519.94%-184.29%
Free Cash Flow Growth (3y) 18.04%20.81%8.72%13.32%-80.48%-86.47%-93.72%
Free Cash Flow (QoQ) -19.43%-30.35%249.23%-124.24%-0.72%18.35%-261.05%38.80%-32.30%23.31%-35.20%60.77%-7.71%-99.63%385.49%-197.92%-11.09%8.45%
Net Cash Flow Growth (1y) 36.48%47.51%87.69%42.61%-1,461.70%508.91%-704.69%-93.97%87.80%-162.21%105.18%6.91%26.81%160.25%164.50%
Net Cash Flow Growth (3y) -6.57%-10.11%27.06%-54.87%-11.72%52.30%45.86%
Net Cash Flow (QoQ) -17.41%-306.65%305.75%-106.47%2.99%4.61%2,482.99%-170.82%125.40%-287.72%117.85%-243.36%-29.50%115.64%268.20%-198.15%206.60%-31.34%
Net Income Growth (1y) -163.60%-224.76%-171.16%33.78%29.50%25.54%-20.97%561.54%-181.81%-210.39%-144.58%
Net Income Growth (3y) -73.66%-95.79%-100.19%
Net Income (QoQ) 10.64%-4.51%-132.93%-21.17%-10.10%12.74%43.12%-29.00%-16.28%-41.77%317.02%-178.77%-28.07%-11.72%
Net Income towards Common Stockholders Growth (1y) -163.60%-224.76%-171.16%33.78%29.50%25.54%-20.97%561.54%-181.81%-210.39%-144.58%
Net Income towards Common Stockholders Growth (3y) -73.66%-95.79%-100.19%
Net Income towards Common Stockholders (QoQ) 10.64%-4.51%-132.93%-21.17%-10.10%12.74%43.12%-29.00%-16.28%-41.77%317.02%-178.77%-28.07%-11.72%
Net Margin Growth (1y) -9.25M-20.47M20.30M0.28M0.09M
Net Margin Growth (3y) 0.06M0.11M0.33M
Net Margin (QoQ) -0.03M-0.21M-11.25M0.20M0.11M-0.05M0.02M0.01M
Operating Income Growth (1y) -163.60%-224.76%-171.16%33.78%29.50%25.54%-20.97%561.54%-181.81%-210.39%-144.58%
Operating Income Growth (3y) -73.66%-95.79%-100.19%
Operating Income (QoQ) 10.64%-4.51%-132.93%-21.17%-10.10%12.74%43.12%-29.00%-16.28%-41.77%317.02%-178.77%-28.07%-11.72%
Operating Margin Growth (1y) -9.25M-20.47M20.30M0.28M0.09M
Operating Margin Growth (3y) 0.06M0.11M0.33M
Operating Margin (QoQ) -0.03M-0.21M-11.25M0.20M0.11M-0.05M0.02M0.01M
Profit After Tax Growth (1y) -106.36%-170.56%-125.82%50.32%31.21%27.94%-28.67%796.62%-229.77%-258.60%-167.41%
Profit After Tax Growth (3y) -67.29%-91.21%-98.07%
Profit After Tax (QoQ) 11.45%-2.54%-119.19%-3.69%-16.10%14.42%51.78%-43.58%-21.61%-52.83%361.05%-167.97%-32.24%-13.97%
Property, Plant & Equipment (Net) Growth (1y) 51.59%25.25%-99.21%356.94%-75.97%-76.10%4,013.33%74.47%5.48%7.07%36.63%79.27%74.51%69.03%43.42%
Property, Plant & Equipment (Net) Growth (3y) -27.30%-31.56%-23.82%142.68%-23.80%-24.37%331.96%
Property, Plant & Equipment (Net) (QoQ) 23.77%-3.88%-96.22%3,275.00%2.26%-99.40%2,093.33%77.51%1.71%3.87%-6.97%7.32%3.25%32.55%22.06%4.47%0.00%12.47%
Return on Assets Growth (1y) -15.00-10.00-2.001.0027.0019.007.001.00
Return on Assets (QoQ) -4.00-6.00-6.001.001.002.00-2.0026.00-7.00-11.00-8.00
Return on Capital Employed Growth (1y) -15.00-10.00-2.000.00M27.0019.004.00-1.00
Return on Capital Employed (QoQ) -5.00-6.00-6.002.001.001.00-4.0029.00-8.00-13.00-9.00
Return on Equity Growth (1y) -16.00-10.00-2.001.0028.0016.00-2.00-24.00
Return on Equity (QoQ) -4.00-6.00-6.001.002.001.00-3.0028.00-10.00-17.00-25.00
Return on Sales Growth (1y) 0.00M0.01M0.00M
Return on Sales (QoQ) -0.01M0.01M0.00M-24.00-25.00-11.00
Revenue Growth (1y) -96.98%-97.84%4,900.00%3,043.40%1,471.62%
Revenue Growth (3y) 129.11%223.56%456.09%
Revenue (QoQ) -30.02%-59.27%-50.00%313.60%4,086.70%-90.79%97.13%106.79%
Share-based Compensation Growth (1y) -93.84%-92.47%-90.83%142.51%752.27%489.33%467.17%-52.17%47.33%60.39%37.64%87.14%59.82%59.61%58.42%
Share-based Compensation Growth (3y) -8.20%-10.73%-10.56%33.52%171.75%147.10%131.26%
Share-based Compensation (QoQ) 10.39%6.11%-323.25%102.36%34.85%29.21%935.43%-52.76%-6.76%24.36%-12.69%45.52%1.51%6.72%18.71%24.28%1.38%5.92%
Shareholder's Equity Growth (1y) -20.44%-20.27%-19.59%972.70%-10.94%-10.85%-11.15%-15.44%-14.28%-13.40%-15.30%11.28%2.28%-10.65%-26.53%
Shareholder's Equity Growth (3y) -15.31%-14.93%-15.42%116.96%-7.91%-11.64%-17.93%
Shareholder's Equity (QoQ) -5.13%-5.01%-109.41%1,037.77%-4.92%-4.20%2.18%-4.30%-4.83%-4.53%-2.75%-2.99%-3.85%-6.63%27.77%-10.83%-16.01%-23.22%